ACE and SGLT2 Inhibitors: The Future for non-Diabetic and Diabetic Proteinuric Renal Disease
Stronger GH pulse Complementary action amplifies GH release
Strategies for Minimizing Side Effects There are practical steps you can take to reduce the intensity of side effects during the adjustment period
New Guidance Reflects a Change in Thinking Recent national guidance from several medical societies now recommends a more tailored approach
Omniverses reinforcement learning (via Isaac Lab and cuOpt) could automatically propose an optimal floorplan or piping layout that humans might not conceive
Elevated TMAO levels have been linked to a number of diseases, including cardiovascular and neurological disorders, renal disease, metabolic syndrome, obesity, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), cancer, and severe COVID-19